Share Buyback in H. Lundbeck A/S


During any one single trading day a maximum of 25% of the average
daily trading volume of Lundbeck shares on OMX Nordic Exchange
Copenhagen, calculated over 20 days prior to each trading date, will
be bought back, as the share buyback program is implemented in
accordance with the provisions of the European Commission's
regulation no. 2273/2003 of December 22, 2003.

At least once every seven trading days, Lundbeck will issue an
announcement in respect of the transactions made under the program.

The following transactions have been made under the program:


                       No. of shares        Average Transaction value
                                     purchase price             (DKK)
                                              (DKK)
Accumulated, last         26,984,134       135.6482     3,660,349,127
announcement
28 January 2008              100,000       118.3291 11,832,913.50
29 January 2008                8,393       119.0595 999,266.38
30 January 2008              104,100       122.3011 12,731,546.59
31 January 2008              102,400       120.4542 12,334,514.18
1 February 2008                   --             -- --
4 February 2008               50,361       122.9815 6,193,469.31
5 February 2008              100,700       121.6697 12,252,143.01
Accumulated under the     27,450,088       135.3982     3,716,692,980
program


Following the above buyback it is hereby announced that Lundbeck owns
a total of 8,293,301 own shares at a nominal value of DKK 5, equal to
4.00% of the total number of 207,279,631 shares.

The content of this release will have no influence on the Lundbeck
Group's financial results for the 2007 financial year, due to be
announced on 4 March 2008. On the same occasion, Lundbeck will
present its financial guidance for 2008.

Lundbeck contacts


Investors:                    Media:

Jacob Tolstrup                Anders Schroll
Director, Corporate Reporting Head of Communication
+45 36 43 30 79               +45 36 43 20 81

Palle Holm Olesen
Head of Investor Relations
+45 36 43 24 26


                      ________________________

Stock Exchange Release No 322 - 5 February 2008

About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2006,
the company's revenue was DKK 9.2 billion (approximately EUR 1.2
billion or USD 1.6 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com

Attachments

Release No 322 in pdf format